Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )

Targeted Anti-cancer Therapies (TAT) conference roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Targeted Anti-cancer Therapies (TAT) conference roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

I-SPY 2 trial shows promising development for some breast cancer patients using...

Dr John W. Park - University of California, San Francisco Hellen Diller Family...

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )

Genetic testing can improve selection of women with ER positive breast cancer...

Prof Mitch Dowsett - The Institute of Cancer Research, London, UK

Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy ( Prof Mitch Dowsett - The Institute of Cancer Research, London, UK )

EBCC 2014 key messages to doctors

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK

EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )

Ganetespib in first-line treatment of women with metastatic HER2 positive or...

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche...

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )

Mechanisms of action and robotics in mCRPC

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China

Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang

mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )

Cost constraints affect treatment decision-making in China and Singapore...

Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran

Cost constraints affect treatment decision-making in China and Singapore - expert discussion ( Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran )

More from ecancer